Previous studies have shown that the m6A RNA methylase METTL3 promotes glioma progression by stabilizing the expression of SOX2, suggesting an important role of m6A modifications in glioma (Somasundaram, 2018; Visvanathan et al., 2018). Here, METTL3 is linked to central nervous system cancer.